May 7, 2024
Loading...
You are here:  Home  >  'biotechnology'
Latest

MannKind reports loss but record revenue for Q3

By   /  Tuesday, November 8th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Tri-County Public Companies, Ventura County  /  Comments Off on MannKind reports loss but record revenue for Q3

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Atara shares drop after larger Q3 loss than expected

By   /  Tuesday, November 8th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Tri-County Public Companies, Ventura County  /  Comments Off on Atara shares drop after larger Q3 loss than expected

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Arcutis reports Q3 loss, but first product revenue

By   /  Tuesday, November 8th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Tri-County Public Companies, Ventura County  /  Comments Off on Arcutis reports Q3 loss, but first product revenue

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Atara treatment nears European approval

By   /  Monday, October 31st, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, middle, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Atara treatment nears European approval

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen shares up amid optimism over experimental weight-loss drug

By   /  Thursday, October 13th, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, left, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Amgen shares up amid optimism over experimental weight-loss drug

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Company backed by Westlake Village BioPartners closes $300M capital raise

By   /  Tuesday, September 13th, 2022  /  Health Care & Life Science, Latest news, Regions, Startups, Subscriber content, Ventura County  /  Comments Off on Company backed by Westlake Village BioPartners closes $300M capital raise

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Atara announces plan to cut workforce by 20%

By   /  Tuesday, August 9th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, left, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Atara announces plan to cut workforce by 20%

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.